Related Experiment Video
Updated: Jun 25, 2026
10:41
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
Biomarkers for tuberculosis disease activity, cure, and relapse
Robert S Wallis1, T Mark Doherty, Phillip Onyebujoh
1Pfizer, New London, USA.
The Lancet. Infectious Diseases
|February 28, 2009
Summary
Biomarkers can accelerate tuberculosis drug development by serving as surrogate endpoints. Further validation in diverse populations and treatment trials is crucial for global tuberculosis control.
Area of Science:
- Medical research
- Infectious diseases
- Biotechnology
Background:
- Global tuberculosis elimination requires novel drugs, vaccines, and therapies.
- Biomarkers are essential tools for accelerating the development of new tuberculosis treatments.
- Validated surrogate endpoints can enhance statistical power in clinical trials.
Purpose of the Study:
- To review the role of biomarkers in tuberculosis drug development.
- To outline criteria for effective candidate tuberculosis biomarkers.
- To highlight the need for further validation of biomarkers in clinical trials.
Main Methods:
- Review of existing literature on tuberculosis biomarkers.
- Analysis of criteria for biomarker validation.
- Discussion of challenges and future directions in biomarker research.
Main Results:
- Numerous candidate biomarkers show promise but require further validation.
- Few studies meet international research standards or include clinically meaningful outcomes.
- Biomarkers must demonstrate differentiation of active disease, normalization with therapy, and predictive value.
Conclusions:
- Biomarkers are critical for efficient tuberculosis drug development.
- Rigorous validation in diverse populations and treatment trials is necessary.
- Multidisciplinary collaboration is essential for advancing biomarker research and tuberculosis control.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...